AxoGen, Inc. Reports 2018 First Quarter Financial Results
Apr 30, 2018 20:05 pm UTC| Business
ALACHUA, Fla., April 30, 2018 -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today reported financial results and business highlights for...
Apr 30, 2018 20:06 pm UTC| Business
BOSTON, April 30, 2018 -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced its theme and plans for Brain Tumor Awareness Month...
The Scotts Miracle-Gro Company Announces Quarterly Dividend Payment
Apr 30, 2018 20:05 pm UTC| Business
MARYSVILLE, Ohio, April 30, 2018 -- The Scotts Miracle-Gro Company (NYSE:SMG), the world’s leading marketer of branded consumer lawn and garden products, announced today that its Board of Directors has approved the...
YRC Worldwide Completes CEO Succession Plan
Apr 30, 2018 20:05 pm UTC| Business
Darren Hawkins named Chief Executive OfficerJames Welch to serve as a Senior Advisor OVERLAND PARK, Kan., April 30, 2018 -- YRC Worldwide Inc. (NASDAQ:YRCW) today announced that Darren Hawkins has been appointed Chief...
Quantenna Announces First Quarter 2018 Financial Results
Apr 30, 2018 20:05 pm UTC| Business
SAN JOSE, Calif., April 30, 2018 -- Quantenna Communications, Inc. (NASDAQ:QTNA), a global leader and innovator of leading-edge performance Wi-Fi solutions, today announced preliminary unaudited financial results for...
Financial Institutions, Inc. Announces Retirement of CFO Kevin B. Klotzbach
Apr 30, 2018 20:05 pm UTC| Business
WARSAW, N.Y., April 30, 2018 -- Financial Institutions, Inc. (NASDAQ:FISI) (the “Company”), parent company of Five Star Bank (the “Bank”), Scott Danahy Naylon, LLC and Courier Capital, LLC, announced today that Kevin B....
Apr 30, 2018 20:05 pm UTC| Business
- Oral Selinexor Achieves 25.4% Overall Response Rate and Median Duration of Response of 4.4 Months in Patients with Penta-Refractory Myeloma - - Company Plans to Submit a New Drug Application to the FDA in the Second...